CEACAM5 and malignant colon neoplasm: Cancer-specific RNA, DNA modification, or secreted molecules have been used as cancer biomarkers, such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19–9 (CA19-9) in colon cancer [19]-[21].